Patient self-report for evaluating mild cognitive impairment and prodromal Alzheimer's disease

Patient-reported outcome (PRO) measures are used to evaluate disease and treatments in many therapeutic areas, capturing relevant aspects of the disorder not obtainable through clinician or informant report, including those for which patients may have a greater level of awareness than those around t...

Descripción completa

Detalles Bibliográficos
Autores principales: Frank, Lori, Lenderking, William R, Howard, Kellee, Cantillon, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308024/
https://www.ncbi.nlm.nih.gov/pubmed/22152342
http://dx.doi.org/10.1186/alzrt97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308024/
https://www.ncbi.nlm.nih.gov/pubmed/22152342
http://dx.doi.org/10.1186/alzrt97

Ejemplares similares